Morphine Withdrawn Phase 3 Trials for Short Gut / Short Bowel Syndrome (SBS) / Short Gut Syndrome / SBS / Short Bowel Treatment

WithdrawnTreatment3 IdentifierTitleDrugs
NCT02242656A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals